Christian Dittrich

Phase II Study of Temsirolimus (CCI-779), a Novel Inhibitor of mTOR, in Heavily Pretreated Patients With Locally Advanced or Metastatic Breast Cancer

Stephen Chan, M. E. Scheulen, S. Johnston et al. · Journal of Clinical Oncology · 2005 · 468 citations · Full text

Medicine, Oncology, Pharmacology +16

2-¹⁸fluoro-deoxy-D-glucose Positron Emission Tomography Is a Reliable Predictor for Viable Tumor in Postchemotherapy Seminoma: An Update of the Prospective Multicentric SEMPET Trial

Maria De Santis, Alexander Becherer, Carsten Bokemeyer et al. · Journal of Clinical Oncology · 2004 · 424 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials

Ignace Vergote, Corneel Coens, Matthew Nankivell et al. · The Lancet Oncology · 2018 · 306 citations · Full text

Medicine, Oncology, Surgery +13

Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1–3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with <i>FGFR3</i> Alterations

Sumanta K. Pal, Jonathan E. Rosenberg, Jean Hoffman‐Censits et al. · Cancer Discovery · 2018 · 257 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients

Robert Königsberg, Eva Obermayr, Giovanna Bises et al. · Acta Oncologica · 2011 · 239 citations · Full text

Medicine, Cell Biology, Oncology +16